Changes in angiotensin converting enzyme (ACE) derived from plasma, lung, aorta, brain, kidney and testis were measured in rats treated with penndopril. Angiotensin converting enzyme was measured by a radio inhibitor binding method using 1251351 A. Rats were gavage fed perindopnl (1,4 and 8 mg/kg) and changes followed over 48 hr. Plasma and kidney ACE were both affected acutely with reduction of 1251351 A binding to less than 5 % of that in control animals 1 and 2 hr after gavage. Ugand binding to ACE in plasma and kidney returned to control levels after 24 hr. Ugand binding to ACE in lung, aorta and brain also was displaced after perindopril treatment. Changes were of a lesser degree than in plasma or kidney. Maximal effect was 1 to 4 hr a...
The release of angiotensin-converting enzyme (ACE) (EC 3.4.15.1) from aortic rings and the modulatio...
Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptor...
The release of angiotensin-converting enzyme (ACE) (EC 3.4.15.1) from aortic rings and the modulatio...
Two methods of radio-inhibitor binding to tissue membrane homogenates and in vitro autoradiography h...
There is increasing evidence that inhibition of tissue angiotensin converting enzyme (ACE) is import...
Inhibition of angiotensin-converting enzyme (ACE) in rat plasma and tissue was studied after adminis...
1. Angiotensin converting enzyme (ACE) from the rat heart and lung was studied by use of the radioli...
To evaluate the mechanisms and the impact of the ACE-inhibitor perindopril (P) in a model of doxorub...
The new orally active angiotensin converting enzyme (ACE) inhibitor perindopril was evaluated in nor...
The new orally active angiotensin converting enzyme (ACE) inhibitor perindopril was evaluated in nor...
The new orally active angiotensin converting enzyme (ACE) inhibitor perindopril was evaluated in nor...
The transgenic rat TGR(mRen-2)27 develops evere hypertension with high adrenal renin and low kid-ney...
The new orally active angiotensin converting enzyme (ACE) inhibitor perindopril was evaluated in nor...
Hypertension is a common presenting factor in Polycystic Kidney Disease (PKD) patients prior to the ...
of chronic ANG I-converting enzyme inhibition on aging processes. I. Kidney structure and function. ...
The release of angiotensin-converting enzyme (ACE) (EC 3.4.15.1) from aortic rings and the modulatio...
Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptor...
The release of angiotensin-converting enzyme (ACE) (EC 3.4.15.1) from aortic rings and the modulatio...
Two methods of radio-inhibitor binding to tissue membrane homogenates and in vitro autoradiography h...
There is increasing evidence that inhibition of tissue angiotensin converting enzyme (ACE) is import...
Inhibition of angiotensin-converting enzyme (ACE) in rat plasma and tissue was studied after adminis...
1. Angiotensin converting enzyme (ACE) from the rat heart and lung was studied by use of the radioli...
To evaluate the mechanisms and the impact of the ACE-inhibitor perindopril (P) in a model of doxorub...
The new orally active angiotensin converting enzyme (ACE) inhibitor perindopril was evaluated in nor...
The new orally active angiotensin converting enzyme (ACE) inhibitor perindopril was evaluated in nor...
The new orally active angiotensin converting enzyme (ACE) inhibitor perindopril was evaluated in nor...
The transgenic rat TGR(mRen-2)27 develops evere hypertension with high adrenal renin and low kid-ney...
The new orally active angiotensin converting enzyme (ACE) inhibitor perindopril was evaluated in nor...
Hypertension is a common presenting factor in Polycystic Kidney Disease (PKD) patients prior to the ...
of chronic ANG I-converting enzyme inhibition on aging processes. I. Kidney structure and function. ...
The release of angiotensin-converting enzyme (ACE) (EC 3.4.15.1) from aortic rings and the modulatio...
Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptor...
The release of angiotensin-converting enzyme (ACE) (EC 3.4.15.1) from aortic rings and the modulatio...